Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC) [NA]
ClinicalTrials.gov entry EDU-INT-BC describes an educational intervention trial in women with breast cancer, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial) [Phase 2]
A Phase 2 ComboMATCH trial evaluating fulvestrant plus binimetinib for NF1-mutant, hormone receptor-positive metastatic breast cancer was te…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy [Phase 2]
Phase 2 trial HER2HEART-US investigates prevention of cardiotoxicity in breast cancer patients receiving HER2-directed therapy; the study is…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI) [NA]
This entry describes a clinical trial called the Black Breast Cancer Survivor's Intervention (BBCSI) examining social and environmental dete…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms [EARLY_Phase 1]
An EARLY Phase 1 trial is investigating whether tart cherry and omega-3 fatty acids can alleviate aromatase inhibitor-associated musculoskel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer [EARLY_Phase 1]
This is an early-phase clinical trial evaluating the safety and tolerability of postoperative radiotherapy given concurrently with CDK4/6 in…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients [Phase 1, Phase 2]
Clinical trial update for Phase 1/2 study evaluating combinations including HRS-2189 with other agents in advanced/metastatic breast cancer,…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) [Phase 1, Phase 2]
This is an update on an ongoing Phase 1/Phase 2 trial of HER2 FPBMC in metastatic breast and prostate cancer, with status not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial [Phase 2]
The Phase 2 VENT trial evaluating fezolinetant to improve vasomotor symptoms in breast cancer patients on endocrine therapy has been termina…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
This ongoing University of Washington-led study is a Phase 1/2 trial evaluating the [18F]FTT PET imaging agent to quantify PARP expression i…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.
Clinical trial update investigating adherence to cell cycle inhibitors as adjuvant therapy in localized high-risk breast cancer.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab [Phase 2]
A Phase 2 clinical trial evaluating a HER2-directed dendritic cell vaccine in combination with weekly paclitaxel, trastuzumab, and pertuzuma…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Mediterranean Diet and Physical Activity in Breast Cancer Patients Under Hormone Therapy [NA]
Completed clinical trial evaluating the effects of a Mediterranean diet and physical activity on cardiovascular health in breast cancer pati…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients [NA]
A clinical trial update indicating recruitment to evaluate using indocyanine green for sentinel lymph node mapping in breast cancer patients…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease [Phase 3]
Phase 3 clinical trial evaluating PF-07220060 in combination with letrozole for adults with HR-positive, HER2-negative breast cancer who hav…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography [NA]
A clinical trial is evaluating the optimal sequencing of mammography views for women with a history of breast cancer undergoing routine surv…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases
This clinical trial update documents an observational emulation of the MONARCH-3 trial in advanced breast cancer using specialty oncology el…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.
This completed clinical trial update describes real-world treatment patterns and clinical outcomes for patients with HR+/HER2- advanced/meta…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating metronomic capecitabine plus an aromatase inhibitor as first-line therapy for HR-positive, HER2-negative metastatic…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Her2-BATS and Pembrolizumab in Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Her2-BATS in combination with pembrolizumab for metastatic breast cancer has posted results.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: HeartPhone Cancer Survivors Trial 2019 [Phase 1, Phase 2]
The HeartPhone Cancer Survivors Trial (Phase 1/2) sponsored by Penn State University was terminated; results have been posted for breast can…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide [EARLY_Phase 1]
First-in-human Phase 1 PET imaging study of the 18F-αvβ6-binding peptide, a radiotracer targeting αvβ6, is active but not currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Trial of Trastuzumab Deruxtecan in Previously Treated HER2 [Phase 2]
Phase 2 study of trastuzumab deruxtecan in previously treated HER2-positive metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease [Phase 2]
A Phase 2 clinical trial is evaluating whether adding stereotactic body radiotherapy to standard of care improves outcomes for patients with…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. [Phase 1, Phase 2]
A Pfizer-sponsored clinical trial update describing a study of Vepdegestrant in combination with PF-07220060 for advanced or metastatic brea…